Teclistamab
Genmab,Janssen
['multiplemyeloma', 'janssen']
we're committed to exploring possible treatment options for patients with #bloodcancer. don't miss an update on clinical data in patients with relapsed/refractory #multiplemyeloma at #asco23. learn more about our latest data: 
Official Twitter site of JanssenUS, to inform media about company news.  Tweets by our communications team. Review our guidelines here: https://t.co/WrVM19L6Yn